Bioassays of Biotechnological Compounds Platform

Fiocruz’s Network Technological Platforms
The RPT11H sets-up bacterial assays against various strains of gram-positive and gram-negative bacteria considered Multidrug-resistant organisms. The bacterial tests include preliminary assays such as antibiogram, minimum inhibitory concentration, and bactericidal and bacteriostatic activity. The platform also performs viability and cytotoxicity assays against non-cancerous and cancerous cells of human and animal origin, as well as antimalarial assays against the Plasmodium falciparum strain. All assays are standardized for screening all types of substances, whether they are extracts, fractions, isolates, oils, nanoparticles, nanofibers, peptides, etc. This platform is located in FIOCRUZ – Amazonas.